Safety and feasibility of balloon aortic valvuloplasty in non‐TAVI centers: The “BAV for life” experience

To evaluate the safety and the feasibility of balloon aortic valvuloplasty (BAV) procedure made by trained operators in centers not performing transcatheter aortic valve implantation (TAVI).

[1]  G. Galasso,et al.  Big Health Data and Cardiovascular Diseases: A Challenge for Research, an Opportunity for Clinical Care , 2019, Front. Med..

[2]  A. Vahanian,et al.  Effectiveness of Rescue Percutaneous Balloon Aortic Valvuloplasty in Patients With Severe Aortic Stenosis and Acute Heart Failure. , 2017, The American journal of cardiology.

[3]  G. Filardo,et al.  Usefulness of Balloon Aortic Valvuloplasty in the Management of Patients With Aortic Stenosis. , 2017, The American journal of cardiology.

[4]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[5]  Helmut Baumgartner,et al.  Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2017, European heart journal cardiovascular Imaging.

[6]  V. Nkomo,et al.  The Role of Balloon Aortic Valvuloplasty in Patients With Aortic Valve Stenosis and Society of Thoracic Surgeons Risk of 15% or Higher. , 2016, The Annals of thoracic surgery.

[7]  Karol Zbroński,et al.  Outcome prediction following transcatheter aortic valve implantation: Multiple risk scores comparison. , 2016, Cardiology journal.

[8]  E. Tuzcu,et al.  Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial). , 2015, JACC. Cardiovascular interventions.

[9]  J. Coselli,et al.  Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. , 2014, Journal of the American College of Cardiology.

[10]  A. Branzi,et al.  Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  B. Prendergast,et al.  Standalone balloon aortic valvuloplasty: Indications and outcomes from the UK in the transcatheter valve era , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[13]  I. Palacios,et al.  Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era. , 2012, Interventional cardiology clinics.

[14]  P. Serruys,et al.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.

[15]  K. Kent,et al.  Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. , 2010, JACC. Cardiovascular interventions.

[16]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[17]  A. Branzi,et al.  How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? , 2010, Journal of cardiovascular medicine.

[18]  K. Kent,et al.  Correlates and Causes of Death in Patients With Severe Symptomatic Aortic Stenosis Who Are Not Eligible to Participate in a Clinical Trial of Transcatheter Aortic Valve Implantation , 2010, Circulation.

[19]  L. Stevens,et al.  Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  Samin K. Sharma,et al.  Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. , 2005, The American journal of cardiology.

[21]  K S Pieper,et al.  Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. , 1995, Journal of the American College of Cardiology.

[22]  L. Wilkins.  Percutaneous Balloon Aortic Valvuloplasty: Acute and 30‐Day Follow‐up Results in 674 Patients From the NHLBI Balloon Valvuloplasty Registry , 1991, Circulation.

[23]  R. McKay,et al.  The Mansfield Scientific Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications. , 1991, Journal of the American College of Cardiology.